Inactive Instrument

Walgreens Boots Alliance Inc Share Price Nyse

Equities

US9314221097

Drug Retailers

End-of-day quote Nyse
- USD - Intraday chart for Walgreens Boots Alliance Inc
Sales 2024 * 145B 11,580B Sales 2025 * 151B 12,026B Capitalization 15.55B 1,239B
Net income 2024 * -7.16B -570B Net income 2025 * 1.96B 156B EV / Sales 2024 * 0.16 x
Net Debt 2024 * 7.2B 574B Net Debt 2025 * 6.81B 542B EV / Sales 2025 * 0.15 x
P/E ratio 2024 *
-2.16 x
P/E ratio 2025 *
8.47 x
Employees -
Yield 2024 *
7.46%
Yield 2025 *
5.85%
Free-Float 60.81%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 64 22/10/23
Director of Finance/CFO 45 31/01/16
Chairman 83 31/07/12
Members of the board TitleAgeSince
Director/Board Member 57 26/10/22
Director/Board Member 67 28/10/20
Director/Board Member 68 31/03/10
More insiders
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
More about the company